# Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill

> **NCT05825092** · PHASE2 · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 600 (estimated)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Androgel Topical Product
- **DRUG:** Placebo
- **DIAGNOSTIC_TEST:** Physical performance
- **DIAGNOSTIC_TEST:** Muscle strength
- **DIAGNOSTIC_TEST:** Muscular mass
- **DIAGNOSTIC_TEST:** Test: Functional status
- **DIAGNOSTIC_TEST:** Oxygen muscular consumption

## Key facts

- **NCT ID:** NCT05825092
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-21
- **Primary completion:** 2025-09-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05825092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05825092, "Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05825092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*